open access publication

Article, Early Access, 2023

Comparable roles for serotonin in rats and humans for computations underlying flexible decision-making

NEUROPSYCHOPHARMACOLOGY, ISSN 0893-133X, 0893-133X, 10.1038/s41386-023-01762-6

Contributors

Luo, Qiang (Corresponding author) [1] [2] [3] Kanen, Jonathan W. [1] Bari, Andrea [4] Skandali, Nikolina [1] [5] Langley, Christelle 0000-0001-5061-2820 [1] Knudsen, G. M. 0000-0003-1508-6866 [6] [7] Alsio, Johan [1] Phillips, Benjamin U. [1] Sahakian, Barbara J. [1] [2] [3] Cardinal, Rudolf N. [1] [5] Robbins, Trevor W 0000-0003-0642-5977 (Corresponding author) [1] [2] [3]

Affiliations

  1. [1] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England
  2. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  3. [2] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China
  4. [NORA names: China; Asia, East];
  5. [3] Inst Brain Sci, Minist Educ Frontiers Ctr Brain Sci, Shanghai 200433, Peoples R China
  6. [NORA names: China; Asia, East];
  7. [4] Aelis Farma, F-33077 Bordeaux, France
  8. [NORA names: France; Europe, EU; OECD];
  9. [5] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge CB21 5EF, England
  10. [NORA names: United Kingdom; Europe, Non-EU; OECD];

Abstract

Serotonin is critical for adapting behavior flexibly to meet changing environmental demands. Cognitive flexibility is important for successful attainment of goals, as well as for social interactions, and is frequently impaired in neuropsychiatric disorders, including obsessive-compulsive disorder. However, a unifying mechanistic framework accounting for the role of serotonin in behavioral flexibility has remained elusive. Here, we demonstrate common effects of manipulating serotonin function across two species (rats and humans) on latent processes supporting choice behavior during probabilistic reversal learning, using computational modelling. The findings support a role of serotonin in behavioral flexibility and plasticity, indicated, respectively, by increases or decreases in choice repetition ('stickiness') or reinforcement learning rates following manipulations intended to increase or decrease serotonin function. More specifically, the rate at which expected value increased following reward and decreased following punishment (reward and punishment 'learning rates') was greatest after sub-chronic administration of the selective serotonin reuptake inhibitor (SSRI) citalopram (5 mg/kg for 7 days followed by 10 mg/kg twice a day for 5 days) in rats. Conversely, humans given a single dose of an SSRI (20 mg escitalopram), which can decrease post-synaptic serotonin signalling, and rats that received the neurotoxin 5,7-dihydroxytryptamine (5,7-DHT), which destroys forebrain serotonergic neurons, exhibited decreased reward learning rates. A basic perseverative tendency ('stickiness'), or choice repetition irrespective of the outcome produced, was likewise increased in rats after the 12-day SSRI regimen and decreased after single dose SSRI in humans and 5,7-DHT in rats. These common effects of serotonergic manipulations on rats and humans-identified via computational modelling-suggest an evolutionarily conserved role for serotonin in plasticity and behavioral flexibility and have clinical relevance transdiagnostically for neuropsychiatric disorders.

Data Provider: Clarivate